Literature DB >> 19378336

Identification of novel microRNA targets based on microRNA signatures in bladder cancer.

Takahiro Ichimi1, Hideki Enokida, Yasushi Okuno, Ryo Kunimoto, Takeshi Chiyomaru, Ken Kawamoto, Kazuya Kawahara, Kazuki Toki, Kazumori Kawakami, Kenryu Nishiyama, Gozoh Tsujimoto, Masayuki Nakagawa, Naohiko Seki.   

Abstract

MicroRNAs (miRNAs) are small noncoding RNAs that negatively regulate protein-coding genes. To identify miRNAs that have a tumor suppressive function in bladder cancer (BC), 156 miRNAs were screened in 14 BCs, 5 normal bladder epithelium (NBE) samples and 3 BC cell lines. We identified a subset of 7 miRNAs (miR-145, miR-30a-3p, miR-133a, miR-133b, miR-195, miR-125b and miR-199a*) that were significantly downregulated in BCs. To confirm these results, 104 BCs and 31 NBEs were subjected to real-time RT-PCR-based experiments, and the expression levels of each miRNA were significantly downregulated in BCs (p < 0.0001 in all). Receiver-operating characteristic curve analysis revealed that the expression levels of these miRNAs had good sensitivity (>70%) and specificity (>75%) to distinguish BC from NBE. Our target search algorithm and gene-expression profiling in BCs (Kawakami et al., Oncol Rep 2006;16:521-31) revealed that Keratin7 (KRT7) mRNA was a common target of the downregulated miRNAs, and the mRNA expression levels of KRT7 were significantly higher in BCs than in NBEs (p = 0.0004). Spearman rank correlation analysis revealed significant inverse correlations between KRT7 mRNA expression and each downregulated miRNA (p < 0.0001 in all). Gain-of-function analysis revealed that KRT7 mRNA was significantly reduced by transfection of 3 miRNAs (miR-30-3p, miR-133a and miR-199a*) in the BC cell line (KK47). In addition, significant decreases in cell growth were observed after transfection of 3 miRNAs and si-KRT7 in KK47, suggesting that miR-30-3p, miR-133a and miR-199a* may have a tumor suppressive function through the mechanism underlying transcriptional repression of KRT7. Copyright 2009 UICC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19378336     DOI: 10.1002/ijc.24390

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  187 in total

Review 1.  The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases.

Authors:  John R Finnerty; Wang-Xia Wang; Sébastien S Hébert; Bernard R Wilfred; Guogen Mao; Peter T Nelson
Journal:  J Mol Biol       Date:  2010-08-01       Impact factor: 5.469

2.  MicroRNA signatures associated with immortalization of EBV-transformed lymphoblastoid cell lines and their clinical traits.

Authors:  J-E Lee; E-J Hong; H-Y Nam; J-W Kim; B-G Han; J-P Jeon
Journal:  Cell Prolif       Date:  2011-02       Impact factor: 6.831

3.  Serum microRNA-145 as a novel biomarker in human ovarian cancer.

Authors:  Huichao Liang; Zhipeng Jiang; Guie Xie; Yan Lu
Journal:  Tumour Biol       Date:  2015-02-27

4.  MiR-199a suppresses the hypoxia-induced proliferation of non-small cell lung cancer cells through targeting HIF1α.

Authors:  Gang Ding; Gang Huang; He-dai Liu; Hong-xiang Liang; Yu-feng Ni; Zhao-heng Ding; Guo-ying Ni; Hong-wei Hua
Journal:  Mol Cell Biochem       Date:  2013-12       Impact factor: 3.396

5.  MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.

Authors:  Menno R Vriens; Julie Weng; Insoo Suh; Nhung Huynh; Marlon A Guerrero; Wen T Shen; Quan-Yang Duh; Orlo H Clark; Electron Kebebew
Journal:  Cancer       Date:  2011-10-17       Impact factor: 6.860

6.  miR-190-mediated downregulation of PHLPP contributes to arsenic-induced Akt activation and carcinogenesis.

Authors:  Kevin Beezhold; Jia Liu; Hong Kan; Terry Meighan; Vince Castranova; Xianglin Shi; Fei Chen
Journal:  Toxicol Sci       Date:  2011-07-12       Impact factor: 4.849

7.  Comprehensive investigation of aberrant microRNA profiling in bladder cancer tissues.

Authors:  Yanping Wei; Rongquan He; Yuzhuang Wu; Binliang Gan; Peirong Wu; Xiaohui Qiu; Aihua Lan; Gang Chen; Qiuyan Wang; Xinggu Lin; Yingchun Chen; Zengnan Mo
Journal:  Tumour Biol       Date:  2016-06-28

8.  MiR-16 family as potential diagnostic biomarkers for cancer: a systematic review and meta-analysis.

Authors:  Jianxiong Cui
Journal:  Int J Clin Exp Med       Date:  2015-02-15

9.  Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.

Authors:  Zheng Chen; Rama Saad; Peilin Jia; DunFa Peng; Shoumin Zhu; M Kay Washington; Zhongming Zhao; Zekuan Xu; Wael El-Rifai
Journal:  Cancer       Date:  2013-03-01       Impact factor: 6.860

10.  The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.

Authors:  Mariyam Zuberi; Imran Khan; Gauri Gandhi; P C Ray; Alpana Saxena
Journal:  Tumour Biol       Date:  2016-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.